Where does the data come from?

City of Cambridge Open Data (data.cambridgema.gov, dataset fv53-bvhy). Official record: https://data.cambridgema.gov/d/fv53-bvhy

CambridgeLifeSciencesTechnologyPulse / report

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.: Life Sciences, Technology (, MA) — Active

Q: How does Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. compare to other Massachusetts CambridgeLifeSciencesTechnologyPulse records?

No comparable amount is available for this record.

Q: How to monitor Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. and peer general commercial filings records

CambridgeLifeSciencesTechnologyPulse lists new CambridgeLifeSciencesTechnologyPulse records from City of Cambridge Open Data (data.cambridgema.gov, dataset fv53-bvhy) as they are published; a free weekly email digest and paid alerts follow Massachusetts records like this one.

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. (Massachusetts): Life Sciences, Technology (, MA) — Active. Score 50/100. As of 2026-11-03, from City of Cambridge Open Data (data.cambridgema.gov, dataset fv53-bvhy).

Data as of 2026-11-03 · Compiled by Zalwin from City of Cambridge Open Data (data.cambridgema.gov, dataset fv53-bvhy)

Free preview: all 6 published fields of this record are shown below. Locked: 117 related MA CambridgeLifeSciencesTechnologyPulse records and the 6-column CSV export.

Field	Value
Organization	Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.
Classification	Life Sciences, Technology
Status	Active
Location	MA
Reported value	Not stated
Reference ID	1001
Peer records CSV (118 MA records)	🔒 Click to unlock →
CRM-ready export with official source URLs	🔒 Click to unlock →

View the official record

Markdown version

Watch Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of MA records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. + all 118 MA records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · Classification · Status · City · Value · Date · official source URL

Source agency: City of Cambridge Open Data (data.cambridgema.gov, dataset fv53-bvhy)
Data refreshed: 2026-11-03
Refunds on request within 14 days

Search all MA records free →

Browse CambridgeLifeSciencesTechnologyPulse by state and category →

LIVE PUBLIC DATA Source: City of Cambridge Open Data (data.cambridgema.gov, dataset fv53-bvhy) · Last refreshed: Tue, 03 Nov 2026 19:46:43 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

<a href="https://zalwin.com/report/cambridgelifesciencestechnolopulse/alyssum-therapeutics-is-a-biotechnology-company-that-ma--cambridgel-1001" rel="noopener"><img src="https://zalwin.com/badge/listed.svg" alt="Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. on Zalwin public records" width="150" height="28"></a>

Peer benchmark and outreach value: Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. and 118 Massachusetts peers

Your role Typical deal size (USD) Assumed reply-to-deal rate (%)

Massachusetts CambridgeLifeSciencesTechnologyPulse records like this one: 118
Estimated pipeline if you contact every Massachusetts peer: $23,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

50 / 100 Score

Active commercial status.

What is the CambridgeLifeSciencesTechnologyPulse record for Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. in Massachusetts?

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. recorded a life sciences, technology filing (Active) in MA on null.

How does Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. compare to other Massachusetts CambridgeLifeSciencesTechnologyPulse records?

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. vs. top 3 peers

Organization	Location
Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.	MA
Koch Institute for Integrative Cancer Research at MIT.	MA
Bial Biotech Investments Inc	MA
Lunar Station Corp	MA

More Massachusetts public-record feeds

Cambridge MA Food Establishment Permits Pulse in Massachusetts New Executive & Auditor Changes (SEC 8-K) in Massachusetts Cambridge MA Mobile Food Truck Permits Pulse in Massachusetts Credit Union Quarterly Changes, Mergers & New Charters (NCUA Call Reports) in Massachusetts New & Re-Approved E-Rate Service Providers (FCC Form 498 / SPIN) in Massachusetts Newly Licensed Child Care Centers & After-School Programs (TX, NY, PA, WA, MA) in Massachusetts New Grants by Vendor Procurement Need in Massachusetts Somerville MA Applications for Permits and Licenses Pulse in Massachusetts

How to monitor Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. and peer general commercial filings records

Get new CambridgeLifeSciencesTechnologyPulse records like Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get City of Cambridge commercial filing alerts

CambridgeLifeSciencesTechnologyPulse emails new commercial filings from City of Cambridge matching your category and value filters.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Public record data from City of Cambridge Open Data (data.cambridgema.gov, dataset fv53-bvhy). Filtered to commercial organizations; individual consumer and residential records are excluded. A public filing or inspection record is not a finding of fault and does not establish legal liability. Verify directly with City of Cambridge before acting.